Clinical trials

  • SUGAMMADEX for Residual neuromuscular blockade | Neuromuscular blockade reversal
  • NEODIDRO® 0.266 mg for Vitamin D deficiency
  • FESOTERODINE for Alzheimer's disease psychosis
  • BEXICASERIN HYDROCHLORIDE for Developmental and Epileptic Encephalopathies
  • THYTREG for Cardiac transplant rejection
  • BAY 3401016 for Alport syndrome|Chronic kidney disease
  • Obinutuzumab for Sjögren's syndrome
  • CABOZANTINIB for Differentiated thyroid cancer (radioiodine-refractory)
  • DABRAFENIB for Advanced melanoma | Malignant melanoma of skin
  • Pembrolizumab for Non-small cell lung cancer
  • Capecitabine for Triple-negative androgen receptor-positive breast cancer (locally recurrent unresectable or metastatic)
  • CYCLOPHOSPHAMIDE for Hematological malignancy